• Home
  • MyECTS
  • Become a member
  • Contact us

Ectsoc

Ecstoc.org

MENUMENU
  • About
    • Mission & Vision
    • Governance & Transparency
    • Board of Directors
    • Annual General Meeting
    • Committees and Action Groups
      • Executive Committee
      • Communications Committee
      • Community Engagement Committee
      • ECTS Academy
      • Education Committee
      • Clinical Science Committee
      • Research Committee
      • Scientific Programme Committee 2025
    • ECTS Team
    • Membership
      • Individual Membership
      • Corporate Supporters
      • Join us
      • Affiliated Societies
  • ECTS 2025
  • Events
    • Upcoming Congresses
    • Past Congress
    • ECTS Academy Charity Event
    • ICCBH
    • Events
  • Grants & Awards
  • Education
    • PhD Training Course
    • Clinical Training Course in Metabolic Bone Diseases
    • Rare Bone Diseases Webinars
    • Education Resource Center
    • Bone Muscle & Beyond Webinars
    • ECTS-Mellanby Training Course
    • Calendar ECTS Educational Events
  • ECTS Academy
    • About the ECTS Academy
    • ECTS Academy – Members
    • Call for Applications - Basic Scientists
    • Call for Applications - Clinicians
    • ECTS Academy Activities
      • NI Conference Program
      • ECTS Academy Webinar Series
      • ECTS Academy Mentoring Options
      • ECTS Academy Charity Run
    • Visit the ECTS Academy website
  • News
    • ECTS Newsletter
    • News
    • Press Release
    • Image Library
    • Video Library
    • Job Advertisements
You are here: Home / Dr. Fleur van Dijk, MD, PhD

Dr. Fleur van Dijk, MD, PhD

National diagnostic EDS service
London, UK
fleur.dijk@nhs.net

Fleur van Dijk combines research and patient care since she commenced her training in clinical genetics in July 2006. She studied clinical and genetic aspects of hereditary connective tissue disorders, especially Osteogenesis Imperfecta (OI). This research led to the discovery of a new genetic cause of OI in 2009 and other publications focusing on the genetic cause and clinical aspects of OI. In 2010 she wrote a publication together with (inter)national experts in the field of OI on the molecular diagnosis of OI (Best Practice Guidelines). In 2012 she started to work as clinical geneticist and post-doctoral investigator. Together with an international research group, she identified a new X-linked cause of osteoporosis and fractures, which was published in October 2013 in New England Journal of Medicine. Since 2013 she is part of the multidisciplinary expert team treating adults with OI in the Netherlands. In 2015 she accepted a position as lead of the national diagnostic EDS service in London which combines research and patient care for people with monogenetic types of Ehlers Danlos syndrome, a group of connective tissue disorders closely related to OI.

Copyright 2016 ECTS - Disclaimer - Cookies Policy - Privacy Policy - Privacy Centre - Terms of use - Contact us